COVERAGE HUB
$ABCL
2 articles in last 30 days
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
1
RECENT COVERAGE · 2 ARTICLES
Jazz Pharmaceuticals Signs Multi-Program Antibody Discovery Deal With AbCellera
Jazz Pharmaceuticals and AbCellera have entered a multi-program collaboration centered on T-cell engaging multispecific antibodies, a...
AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL)
ABCL presents a valuation inflection point for investors monitoring biotech innovation. The company trades at depressed levels relative...
RELATED TICKERS